Related Experiment Videos
Asymptomatic structural liver disease in hemophilia
The New England Journal of Medicine
|June 22, 1978
Summary
Hepatitis B virus persists in the liver cells of hemophilic patients despite antibody presence. This may cause liver damage due to blood product treatments.
Area of Science:
- Hepatology
- Virology
- Hematology
Background:
- Hemophilic patients often receive blood product transfusions.
- Chronic liver function abnormalities are observed in some hemophilic patients.
- Hepatitis B virus (HBV) is a concern in transfusion recipients.
Purpose of the Study:
- To investigate liver histology and HBV presence in hemophilic patients with abnormal liver function tests.
- To determine the relationship between blood product exposure and liver pathology in this cohort.
Main Methods:
- Analysis of 14 liver biopsies from 13 anti-HBs-positive hemophilic patients.
- Histopathological examination including chronic persistent hepatitis, chronic active hepatitis, and fatty infiltration.
- Indirect immunofluorescence to detect hepatitis B viral markers (anti-HBs, anti-HBc) in hepatocytes.
Main Results:
- None of the patients had symptomatic liver disease.
- Chronic hepatitis or fibrosis was observed in all biopsied patients.
- Hepatitis B viral markers were detected in hepatocytes of 8 out of 12 patients studied.
Conclusions:
- Hepatitis B virus can persist in hepatocytes of hemophilic patients, even with circulating antibodies.
- Blood product transfusions may contribute to liver damage and HBV persistence.
- Histological abnormalities suggest ongoing liver injury in these patients.